micafungin and Diabetic-Ketoacidosis

micafungin has been researched along with Diabetic-Ketoacidosis* in 2 studies

Other Studies

2 other study(ies) available for micafungin and Diabetic-Ketoacidosis

Article	Year
A case of invasive pulmonary aspergillosis diagnosed by transbronchial lung biopsy during treatment for diabetic ketoacidosis in a type 1 diabetic patient. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020, Volume: 26, Issue:2 Invasive pulmonary aspergillosis (IPA) patients with non-hematological malignancy are far less than with hematological malignancy patients. We encountered a very rare case of IPA in which type 1 diabetes was the only conceivable risk factor. Further, according to the diagnostic categories of the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) criteria for IPA, the frequency of proven diagnosis is very low. Here we report a proven IPA, which rapidly developed when the patient with type 1 diabetes was being treated for diabetic ketoacidosis, which was successfully treated with the combination therapy of voriconazole (VRCZ) and micafungin (MCFG), based on early diagnosis using bronchoscopy. Topics: Antifungal Agents; Aspergillus fumigatus; Biopsy; Bronchoalveolar Lavage Fluid; Bronchoscopy; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Insulin; Invasive Pulmonary Aspergillosis; Male; Micafungin; Middle Aged; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole	2020
Dysphagia, Hyperglycemia, and Presyncope. Dysphagia, 2018, Volume: 33, Issue:6 There have been over 80 documented cases of swallow syncope-a rare form of reflex or neurally mediated syncope-with most cases associated with an underlying esophageal disorder. Here, we describe the first reported case of swallow syncope or presyncope caused by an infectious esophagitis. Our 65-year-old patient initially developed dysphagia, odynophagia, and presyncope with swallowing. This lead to nutrition and medication avoidance behavior, which was followed by the development of diabetic ketoacidosis. The diagnosis of swallow presyncope was confirmed with a provocative swallow study demonstrating 8 s sinus arrest, and an underlying cause of Candida esophagitis was found by upper endoscopy. Symptoms completely resolved after treatment with micafungin. Topics: Aged; Antifungal Agents; Candida; Candidiasis; Deglutition Disorders; Diabetic Ketoacidosis; Esophagitis; Female; Humans; Micafungin; Syncope	2018

Article

Year

A case of invasive pulmonary aspergillosis diagnosed by transbronchial lung biopsy during treatment for diabetic ketoacidosis in a type 1 diabetic patient.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020, Volume: 26, Issue:2

Invasive pulmonary aspergillosis (IPA) patients with non-hematological malignancy are far less than with hematological malignancy patients. We encountered a very rare case of IPA in which type 1 diabetes was the only conceivable risk factor. Further, according to the diagnostic categories of the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) criteria for IPA, the frequency of proven diagnosis is very low. Here we report a proven IPA, which rapidly developed when the patient with type 1 diabetes was being treated for diabetic ketoacidosis, which was successfully treated with the combination therapy of voriconazole (VRCZ) and micafungin (MCFG), based on early diagnosis using bronchoscopy.

Topics: Antifungal Agents; Aspergillus fumigatus; Biopsy; Bronchoalveolar Lavage Fluid; Bronchoscopy; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Insulin; Invasive Pulmonary Aspergillosis; Male; Micafungin; Middle Aged; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole

2020

Dysphagia, Hyperglycemia, and Presyncope.

Dysphagia, 2018, Volume: 33, Issue:6

There have been over 80 documented cases of swallow syncope-a rare form of reflex or neurally mediated syncope-with most cases associated with an underlying esophageal disorder. Here, we describe the first reported case of swallow syncope or presyncope caused by an infectious esophagitis. Our 65-year-old patient initially developed dysphagia, odynophagia, and presyncope with swallowing. This lead to nutrition and medication avoidance behavior, which was followed by the development of diabetic ketoacidosis. The diagnosis of swallow presyncope was confirmed with a provocative swallow study demonstrating 8 s sinus arrest, and an underlying cause of Candida esophagitis was found by upper endoscopy. Symptoms completely resolved after treatment with micafungin.

Topics: Aged; Antifungal Agents; Candida; Candidiasis; Deglutition Disorders; Diabetic Ketoacidosis; Esophagitis; Female; Humans; Micafungin; Syncope

2018